Drawing for BRAID

USPTO serial 99337421

BRAID

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MAKHDOOM, SAIMA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with BRAID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $224*

Plus Government fees of $125

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew J. Ferren

Andrew J. Ferren Goulston & Storrs PCOne Post Office Square25th FloorBoston, MA 02109

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SaaS) services featuring software using artificial intelligence to improve the design and operational efficiency of clinical trials by means of generating actionable insights, predictions, and workflow automation; Software as a service (SaaS) services featuring software using artificial intelligence to extract structured and unstructured data from clinical trial protocols to create, de-identify, encrypt, standardize and tokenize machine readable data for use in the field of clinical research; Software as a service (SaaS) featuring software for use in providing a data clean room enabling researchers to securely access and analyze digitized clinical trial protocol data for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to optimize clinical research protocols and study feasibility by benchmarking a given protocol against the operational outcomes of similar past protocols for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence that enables researchers to engage in predictive planning to model the budget, timeline, enrollment, site performance, and investigator trends for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to automate Institutional Review Board (IRB) workflow for submission validation, conversational guidance and digital protocol delivery for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to enable research study startup workflows that digitize artifacts, research site communications, predictive planning, and regulatory tracking for accelerated initiation of research sites for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence and integrated workflow automation to plan, track, and manage clinical trial operations at research sites effectively with real-time visibility to identify opportunities for further efficiency; Providing temporary use of online non-downloadable chatbot software using artificial intelligence to respond to natural language queries from researchers with charts, summaries, and follow-up prompts for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to create research data visualizations that automatically generate dashboards, graphing, and charting for evidence-backed insights for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to forecast and recommend actions that enable researchers to improve the design, planning, and execution of clinical trials for use in the field of clinical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 29, 2026ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 29, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 29, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 30, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 2, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 1, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2025DOCKASSIGNED TO EXAMINER—
Aug 14, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 14, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance